This analysis describes what Apple's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
The updated guidelines do not directly affect end users of apps, but they establish new requirements for developers submitting apps to the App Store. Developers must now provide regulatory documentation for apps requiring approval, implement content moderation safeguards for user-generated content and AI content creation platforms, and ensure all app information and creative assets meet specific accuracy and appropriateness standards. Developers who fail to implement safeguards or remediate violations after notice may be considered in violation of the Developer Code of Conduct, potentially resulting in app removal or account termination.
View change record →How other platforms handle this
we reserve the right to limit quantities on orders placed by the same account, on orders placed by the same method of payment, and on orders that use the same billing or shipping address.
Depending on how a user interacts with the Service, including which modes the user purposely selects, the Service may have content such as some suggestive dialogue, coarse language, crude humor, sexual situations, or violence.
Some of our Content may be offered in limited territories, and we may use geofiltering technology to restrict access outside of those territories.
"Medical apps that could provide inaccurate data or information...may be reviewed with greater scrutiny. Apps must clearly disclose data and methodology to support accuracy claims relating to health measurements...Excerpt from Apple's App Store Review Guidelines
Get the weekly coverage letter
Companies change their terms without announcing it. We capture governance documents, compare each new version with the last, and publish what changed, with the source text behind it. One email a week on what we found and what we could not reach.
The clause states: “Medical apps that could provide inaccurate data or information...may be reviewed with greater scrutiny. Apps must clearly disclose data and methodology to support accuracy claims relating to health measurements...”
ConductAtlas has identified this type of provision across 237 platforms. See the full comparison.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by Apple.